Chemiluminescence (CL) analysis offers high sensitivity, wide linear range and a simple instrument. When coupled with flowinjection analysis (FIA), CL-based FIA methods provide a cheap, rapid, simple and reproducible means of detection and have therefore been successfully applied to the detection of many drugs. [1] [2] [3] [4] [5] Many oxidants, including oxygen, hydrogen peroxide, hypochlorite, iodine, cerium(IV), ferricyanide, permanganate, perborate, and persulfate, have been used extensively in CL reactions. Electrogenerated CL oxidants, such as hypobromite, hypochlorite, Co 3+ , Ag 2+ , and Mn
, Ag 2+ , and Mn
3+
, have also been introduced to CL systems with the advantage of stability and sensitivity.
NBS has been extensively used as a brominating and oxidizing reagent. 6 Halvatzis et al. 7 first introduced NBS into CL coupled with flow-injection analysis for the determination of isoniazid in pharmaceutical preparations. In aqueous solutions, its oxidizing properties were attributed to hypobromous acid generated by its hydrolysis. 8 A great advantage of using NBS instead of hypobromite is the relatively good stability of this reagent. 9, 10 The use of NBS as a source of hypobromite creates an alternative for more complicated approaches, like the electrogeneration of this reagent. 11 Hitherto, many analytical procedures were successfully developed using NBS as an efficacious CL oxidant. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Phenformin (phenethydiguanide) (Fig. 1 ) is known to be used as an oral antihyperglycemic drug in the treatment of noninsulin-dependent diabetes mellitus. 22 Although in some areas it has been prohibited for health or safety reasons, it was still extensively used as a valid antihyperglycemic drug in many other countries when its application was properly controlled. Thus, an accurate and highly sensitive determination of phenformin is of great importance for different purposes.
Analytical methods available for the determination of phenformin in Chemical Abstract from 1992 -2002 mainly included spectrophotometric, [23] [24] [25] HPLC, 26, 27 reversed-phase HPLC, 28 liquid chromatography-mass spectrometry (LC-MS), 29 gas chromatography-mass spectrometry (GC-MS), 30 capillary zone electrophoresis 31 and NMR 32 techniques. Each of these proposed methods often offer their own set of advantages and disadvantages. However, some disadvantages, such as complicated procedures, being time consuming, required expensive instrumentation, or low sensitivity, made these methods not simple, rapid and sensitive for the determination of phenformin. To the best of our knowledge, there is a lack of information concerning the CL detection of phenformin in public literature.
In the present work, a new sensitive enhanced CL assay for the determination of phenformin based on CL oxidation between NBS and phenformin using fluorescein as energy transfer agent is proposed. The use of cetyltrimethylammonium bromide (CTAB) as a sensitizer enhances the signal magnitude by about 100 times. The proposed CL method offers potential advantages of simplicity, rapidity, high sensitivity, as well as a wide calibration range for the determination of phenformin in A novel and highly sensitive method for the determination of phenformin over the range of 6 × 10 -9 -1 × 10 -5 g ml -1 in pharmaceutical formulations with flow-injection chemiluminescence (CL) detection is proposed. The method is based on the CL produced during the oxidation of N-bromosuccinimide (NBS) in an alkaline medium in the presence of fluorescein as an effective energy transfer agent. The use of cetyltrimethylammonium bromide (CTAB) as a sensitizer enhances the signal magnitude by about 100 times. The detection limit is 2 × 10 -9 g ml -1 (3σ) with a relative standard deviation of 2.3% (n = 11) at 1 × 10 -7 g ml -1 phenformin. Ninety samples can be determined per hour. The method was evaluated by carrying out a recovery study and by the analysis of commercial formulations. The obtained results compared well with those by an official method, and demonstrated good accuracy and precision. The possible CL mechanism of the proposed system was also briefly analyzed. pharmaceutical formulations. The results obtained compared well with those by an official method, and demonstrated good accuracy and precision. The possible CL mechanism of the proposed system was also briefly considered.
Experimental

Reagents
Analytical reagent-grade chemicals and deionized, doubly distilled water were used throughout. Phenformin hydrochloride (Drug and Biological Products Examination Bureau of China, Beijing, China) was used as a standard. A stock solution of phenformin hydrochloride (1 × 10 -3 g ml -1 ) was prepared daily and stored in a refrigerator (4˚C). Working standard solutions were prepared from the stock solution by appropriate dilution before use. An NBS solution (0.01 mol l -1 ) was prepared daily by dissolving 1.780 g of NBS (Shanghai Chemical Reagent Company, China) in water, and diluting to 1000 ml in an amber-colored measuring flask. A fluorescein stock solution (5 × 10 -3 mol l -1 ) was prepared by dissolving 0.415 g of fluorescein (Shanghai SSS Reagent Ltd., China) in a 0.05 mol l -1 NaOH solution, and diluting to 250 ml with same NaOH solution. A CTAB stock solution was prepared by dissolving 0.228 g of CTAB (Shanghai Chemical Reagent Company, China) in water, and diluting to 250 ml with water. A stock NaOH solution (1.0 mol l -1 ) was daily prepared by dissolving 4.0 g sodium hydroxide (Chongqing Chemical Reagent Plant, China) in water, and diluting to 100 ml with water.
The possibly minimum number of dilution steps was used to prepare more dilute solutions. All other chemicals were of the best grade available, and were used as received.
Phenformin hydrochloride tablets (No. 1, Shandong Boshan Pharmaceutical Factory, Shandong, China; No. 2, Jintan Pharmaceutical Factory, Jiangsu, China) were obtained from local drug stores.
Apparatus
A schematic diagram of the flow system employed in this work is shown in Fig. 2 . Two peristaltic pumps (type HL-2, manufactured at Huxi Instrument and Meter Plant, Qingpu, Shanghai, China) were used to deliver flow streams in this system. PTFE tubing (0.8 mm i.d.) was used as the connection material in the flow system. Sample solutions (100 µl) were injected into the carrier stream (water) using an eight-way injection valve equipped with a 100 µl sample loop, merged with a mixture of NBS and fluorescein (in 0.05 mol l -1 NaOH and 0.0025 mol l -1 CTAB solution), which then reached the flow cell, producing CL emission. The CL signal produced in the flow cell was detected and recorded with a computerized ultra-weak luminescence analyzer (Type BPCL, manufactured at the Institute of Biophysics, Academia Sinica, Beijing, China). A glass flow cell was located directly facing the window of the CR-105 photomultiplier tube (Hamamatsu, Tokyo, Japan). Data acquisition and treatment were performed with BPCL software running under Windows 98. The chemiluminescence spectrum was monitored using a modified RF-540 fluorescence spectrometer (Shimazhu, Japan).
Procedure
In order to obtain good mechanical and thermal stability, the instruments were run for 20 min before the first measurement. Flow lines were inserted into the NBS solution, fluorescein solution (in 0.05 mol l -1 NaOH and 0.0025 mol l -1 CTAB solution), water carrier and sample solution. A sample stream was fed at a flow rate of 0.5 ml min -1 , and the other streams were all fed at a flow rate 2.5 ml min -1 . The pumps were started to wash the whole system until a stable baseline was recorded. Then, 100 µl of a sample solution was injected into the carrier stream. This stream was merged with the NBS solution and fluorescein solution (in 0.05 mol l -1 NaOH and 0.0025 mol l -1 CTAB solution), which then reached the flow cell, producing CL emission. The concentration of the sample was quantified by the CL intensity.
Results and Discussion
Characteristics of the CL reaction
In the present work, it was found that phenformin could be oxidized by NBS and sensitized by fluorescein to produce high CL emission in basic media. The addition of CTAB can greatly enhance the CL intensity. In order to obtain an idea about the reaction product generating the CL, the CL spectrum of the reaction was examined by a modified RF-540 fluorophotometer (turn off the light source).
Various mix methods were used to arrange the reagents in this CL system. The results indicated that almost no light emission was recorded when only the NBS solution and phenformin solution were mixed together. However, when NBS was mixed with phenformin in the presence of fluorescein under an alkaline condition, there was a strong luminescence peak at around 518 nm (same as the maximum fluorescent emission wavelength of fluorescein in an aqueous solution). The CL intensity was further greatly enhanced after the addition of CTAB into the system. At the same time, a red shift phenomenon occurred for the luminescence peak from 518 nm to 534 nm, which is in agreement with the fluorescence emission peak in a micellar CTAB solution. 33 In aqueous solutions, the oxidizing properties of NBS were attributed to hypobromous acid generated by its hydrolysis. There is a reducing biguanide group in the molecule structure of phenformin, which makes the redox between NBS and phenformin easily occur. The energy generated from the redox reaction may excite fluorescein molecules to their excited states. When they return to the ground state, fluorescence emission arises. The possible effect of CTAB may be changing the kinetics process of energy transfer, reducing the non-radiative internal transfer process when the excited-state molecules return to their ground state, and making the fluorescence quantum yield of fluorescein molecules greatly enhanced. Thus, CL emission could be attributed preliminarily to the process of energy transfer. Namely, fluorescein accepted the energy generated from the redox of NBS with phenformin, and was excited to produce CL. Therefore, the CL mechanism of the reaction in its simplest form may be concluded to be as follows:
NBS + H2O → NHS + HBrO
BrO -+ phenformin + OH -→ product* product* + fluorescein → fluorescein* + product fluorescein* → fluorescein + hν (λmax = 534 nm) where product* is the exited state of the product and fluorescein* is the exited state of the fluorescein molecule.
Optimization of conditions
A series of experiments were conducted to establish the optimum analytical conditions for the CL oxidation of phenformin by NBS in the presence of fluorescein and cationic surfactants.
Effect of the fluorescein concentration
Fluorescent compounds, such as quinine, 8-hydroxyquinoline, rhodamine B, rhodamine 6G, fluorescein, and dichlorofluorescein, were used as energy-transfer reagents for the enhancing of the CL reaction between NBS and phenformin. The highest CL emission and optimum signal/noise ratio were obtained when fluorescein was used. Thus, fluorescein was selected and the effect of its concentration on the CL intensity was further investigated over the range of 1 × 10 -5 -1 × 10 -3 mol l -1 . The result showed that the optimum is 4 × 10 -4 mol l -1 (Fig. 3) . It then was chosen for a subsequent experiment.
Effect of the sodium hydroxide concentration
An alkaline condition is necessary for the NBS CL system. It was found that a small amount of CL emission was observed under acid or neutral conditions. In this work, NaOH was used as the reaction medium for the CL of NBS and phenformin in the presence of fluorescein. Several schemes for NaOH in the CL system, including in NBS, in fluorescein, as the carrier stream, and in samples, were investigated carefully in order to obtain the optimum condition for the detection of phenformin.
The results showed that a low CL baseline and a high CL intensity as well as optimum repeatability were observed when NaOH was arranged in fluorescein. Therefore, NaOH in fluorescein was selected. In a further investigation, it was found that the highest CL emission intensity was obtained when the NaOH concentration was 0.05 mol l -1 (Fig. 4) . Thus, 0.05 mol l -1 NaOH in fluorescein was chosen as the reaction medium for consequent research.
Effect of the NBS concentration
A CL intensity of 5 × 10 -8 g ml -1 phenformin with 4 × 10 -4 mol l -1 fluorescein in 0.05 mol l -1 NaOH was investigated (Fig.  5) . The CL intensity was found to increase with increasing the concentration of NBS in the range of 0.001 -0.01 mol l -1 . A further increase in the NBS concentration resulted in a reduction of the CL intensity. The maximum responses were obtained at 0.01 mol l -1 . Thus, this concentration was chosen as being the most suitable for further studies.
Chemiluminescence enhancement by surfactants
Surfactants are commonly used to increase the efficiency of CL and the sensitivity of the measurement. Therefore, the effect of some typical surfactants, including cetyltrimethylammonium bromide (CTAB), cetylpyridinium chloride (CPC), sodium dioctyl sulfosuccinate (SDS), tween-80, and sodium tetrafluoroborate, on the CL emission from the reaction of NBS with phenformin in the presence of fluorescein was investigated. The results showed that CTAB could be selected as the most suitable sensitizer for the CL system, attributing to its strong effect on the enhancement of the CL intensity for about 100 times and the effective reduction of the CL baseline. The effect of its concentration (CMC: 9.2 × 10 -4 mol l -1 ) on the CL intensity was investigated in the range of 1 × 10 -3 -5 × 10 -3 mol l -1 . The result showed (Fig. 6 ) that the CL intensity increased with the concentration of CTAB in the range of 1 × 10 -3 -2.5 × 10 -3 mol l -1 . No significant increase was observed when the concentration was above 2.5 × 10 -3 mol l -1 . Thus, 2.5 × 10 -3 mol l -1 was chosen as the optimum. 
Effect of the flow rate
The effect of the flow rate on the intensity of the CL system was studied over the range of 0.1 -3.5 ml min -1 in each stream. Although a general improvement in the emission intensity was obtained with an increase in the flow rate over the range of 0.1 -3.5 ml min -1 , a higher flow rate not only led to greater consumption of the reagents, but also caused irreproducibility. Thus, the selected value for flow rate was 0.5 ml min -1 for samples and 2.5 ml min -1 for other streams, at which samples could be analyzed at a rate of 90 solutions per hour, with a relative error of about 3% for 5 × 10 -8 g ml -1 phenformin hydrochloride.
Performance of the proposed method for phenformin measurements
As a result of the optimization procedure, in order to improve the precision of the proposed method for phenformin determination, three linear ranges of a calibration graph were established ( Table 1 ). The detection limit was 2 × 10 -9 g ml -1
(3σ). A complete analysis, including sampling and washing, could be performed in 45 s with a relative standard deviation of 2.3% for 1 × 10 -7 g ml -1 phenformin hydrochloride (n = 11). A typical recording output of the proposed CL system for the determination of different concentrations of phenformin is shown in Fig. 7 .
Interference study
The influences of foreign species and components in commercial preparations of phenformin hydrochloride were investigated by analyzing a standard solution of phenformin hydrochloride of 1 × 10 -7 g ml -1 , to which increasing amounts of interfering species were added. The tolerable concentration ratios with respect to 1 × 2+ and Mn 2+ showed severe interference (over 2-fold of the signal generated by phenformin hydrochloride), which could be eliminated by adding EDTA and citrate into the sample.
Because the contents of coexisting substances and excipients in phenformin hydrochloride commercial tablets are all lower than their tolerable concentrations after certain dilution, the proposed method could be used directly to determine phenformin hydrochloride in its tablets.
Application
Several commercial phenformin tablets were ground to powder, and a portion of the powder was weighed and dissolved in 100 ml of doubly distilled water. After filtering, aliquots of the filter were further diluted with water, so that the concentration of phenformin was in the working range for the determination of phenformin, and were analyzed by the proposed method. The results (Tables 2, 3 ) agreed well with those obtained by the official method. 34 Recoveries from 100 -103% were also achieved ( Table 2) . 
Conclusion
A novel energy-transfer based CL system for the determination of phenformin was successfully developed. The proposed CL method offers the advantages of simplicity, rapidity, sensitivity and accuracy for the determination of phenformin in pharmaceutical preparations. The proposed method is suitable for automatic and continuous analysis, which could be used as an alterative to other methods, such as potentiometric titration, and spectrophotometry, for the determination of phenformin in its commercial formulations.
